Evidence map›Paper›PMID 42298440›Full record

ArticleBMC infectious diseases2026

Evaluating documentation of follow-up laboratory testing in TB treatment monitoring in the Eastern Region of Ghana: a consistency analysis of three facility registers.

Mavis Pearl Kwabla, William Dormechele, Lawrence Sena Tuglo, Ofosuhene O Apenteng, Gideon Kye-Duodu, Eric Osei, Joyce Der, Yaw Adusi-Poku, Frank Baiden

Abstract readEvaluation Study
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mavis Pearl KwablaDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Ho, Ghana. mkwabla@uhas.edu.gh.
William DormecheleNavrongo Health Research Centre, Navrongo, Ghana.
Lawrence Sena TugloDepartment of Nutrition and Dietetics, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana.
Ofosuhene O ApentengUniversity of Copenhagen, Copenhagen, Denmark.
Gideon Kye-DuoduDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Ho, Ghana.
Eric OseiDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Ho, Ghana.
Joyce DerDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Ho, Ghana.
Yaw Adusi-PokuNational TB Control Programme, Ghana Health Service, Accra, Ghana.
Frank BaidenDepartment of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Ho, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) recommends systematic follow-up testing for all bacteriologically confirmed pulmonary TB (PTB) cases under treatment to track progress towards successful treatment completion. However, this topic has received little attention from researchers. We assessed the extent of documentation of follow-up laboratory testing for TB treatment monitoring.

methodsMatched and unmatched records of bacteriologically confirmed PTB cases recorded between January 2016 and December 2017 across three TB registers from five districts of the Eastern Region were analyzed to assess documentation of follow-up laboratory testing at recommended treatment time points (months 2/3, 5, and 6/8). A cross-register consistency analysis assessed agreement between follow-up testing records documented in the laboratory register and those recorded in the district TB register, with the laboratory register treated as the reference source. A logistic regression model was used to identify factors associated with documentation of follow-up laboratory testing.

resultsA total of 773 bacteriologically confirmed PTB cases were successfully matched across the three registers after record linkage. The mean age was 42.6 years (SD = ± 15.0). More than half of the PTB cases in the district register did not have follow-up test results documented at 2 or 3 months (62.9%, 95% CI: 59.4-66.2, p < 0.001), 5 months (72.5%, 95% CI: 69.2-75.5, p < 0.001), and 6 or 8 months (66.4%, 95% CI: 63.0-69.6, p < 0.001). Similarly, in the laboratory register, 45.8% of cases had missing follow-up laboratory test results at months 2 or 3, 65.9% at month 5, and 99.9% at month 6/8. In the treatment centre registers, 67.1%, 75.9%, and 75.4% of PTB cases did not have follow-up test results documented at months 2 or 3, 5, and 6 or 8, respectively. Cross-register consistency analysis showed that documentation status matched in more than half of the records across the assessed follow-up intervals, with the highest consistency observed at month 6/8 (66.3%; 95% CI: 62.8-69.5; p < 0.001). Adult age groups (15-64 years) had lower odds of having documented follow-up test results than children aged 0-14 years. PTB cases from the Kwahu West Municipality were more likely to have documented follow-up testing results (aOR: 3.9, 95% CI: 2.1-7.1, p < 0.001) compared to cases residing in Akyemansa District.

conclusionLogistic regression analysis showed that documented follow-up testing results were less common among several adult age groups than among children aged 0-14 years. Because this study assessed routine register documentation, this finding should be interpreted as a documentation gap rather than a confirmed absence of testing. Strengthening documentation practices and integrated reporting systems for follow-up testing should therefore be prioritized within the TB control programme.

Indexed as

DocumentationRegistriesTuberculosis, PulmonaryAdolescentAdultAntitubercular AgentsFemaleFollow-Up StudiesGhanaHumansMaleMiddle AgedYoung AdultAntitubercular AgentsCross-register consistencyDocumentationFollow-upLaboratory registerLaboratory testingTB controlTreatment monitoringTuberculosis

Identifiers

PMID42298440
PMCPMC13505022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.